REGISTRATION RIGHTS AGREEMENT by and among Alpharma Inc. and the Guarantors Listed on Schedule A hereto Banc of America Securities LLC CIBC World Markets Corp. Dated as of April 24, 2003 Registration Rights AgreementRegistration Rights Agreement • May 14th, 2003 • Alpharma Inc • Pharmaceutical preparations • New York
This Agreement is made pursuant to the Purchase Agreement, dated as of April 16, 2003 (the "Purchase Agreement"), by and among the Company, the Guarantors and the Initial Purchasers (i) for the benefit of each other Initial Purchaser and (ii) for the benefit of the holders from time to time of the Initial Notes (including you and each other Initial Purchaser). In order to induce the Initial Purchasers to purchase the Initial Notes, the Company has agreed to provide the registration rights set forth in this Agreement. The execution and delivery of this Agreement is a condition to the obligations of the Initial Purchasers set forth in Section 5(k) of the Purchase Agreement, and capitalized terms not defined herein are used as defined in the Purchase Agreement.
AMENDMENT NO. 1 TO THE CREDIT AGREEMENTCredit Agreement • May 14th, 2003 • Alpharma Inc • Pharmaceutical preparations • New York
Alpharma Operating Corporation, a Delaware corporation (the "Company"), Alpharma USPD Inc., a Maryland corporation (together with the Company and the Subsidiary Borrowers party thereto, the "Borrowers"), Holdings, the Lender Parties and the Administrative Agent have entered into a Credit Agreement dated as of October 5, 2001 (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement"). Capitalized terms not otherwise defined in this Amendment have the same meanings as specified in the Credit Agreement. Holdings and the Required Lenders have agreed to amend the Credit Agreement as hereinafter set forth.
AMENDMENT NO. 2 TO THE CREDIT AGREEMENTCredit Agreement • May 14th, 2003 • Alpharma Inc • Pharmaceutical preparations • New York
Alpharma Operating Corporation, a Delaware corporation (the "Company"), Alpharma USPD Inc., a Maryland corporation (together with the Company and the Subsidiary Borrowers party thereto, the "Borrowers"), Holdings, the Lender Parties and the Administrative Agent have entered into a Credit Agreement dated as of October 5, 2001, as amended by Amendment No. 1 dated as of December 16, 2002 (as further amended, supplemented or otherwise modified from time to time, the "Credit Agreement"). Capitalized terms not otherwise defined in this Amendment have the same meanings as specified in the Credit Agreement. Holdings and the Required Lenders have agreed to amend the Credit Agreement as hereinafter set forth.
